A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

Summary

The objective of this study is to investigate the safety, tolerability, and pharmacokinetics of MT-2990 in patients with Japanese cedar pollen-induced seasonal allergic rhinitis (JC-SAR). Additional objective of the study is to investigate the efficacy and pharmacodynamics profile of MT-2990 in an environmental exposure chamber (EEC) on Day 8, 29, 57, and 85.

Timeline

Start

2018-07-17

Primary completion

2018-12-27

Completion

2018-12-27

Drugs

Indications